CRO Services Center (Phase IV)

Phase 4 trials, also known as a post-approval studies, post-marketing surveillance trials, or real-world evidence (RWE) studies, are generally conducted after a Phase 3 trial is complete and a drug has received regulatory approval.

In a Phase 4 trial, side effects are studied over time in users of the drug after it has become commercially available. These trials allow the drug to be studied in a real-world population, which can be much more diverse and inclusive than the patients who took part in a Phase 3 clinical trial. The tools and technologies required for a Phase 4 trial are similar to those used in a Phase 3 trial. The conduct of these trials can also be managed by a CRO.

How can we help?

Looking for help with your Phase IV project? If you're searching for information or a supplier, let Clinical Leader lend you a hand.

Submit A Question

CRO Services Center (Phase IV) Provider - Acorn AI
Acron AI

Acorn AI™ is a Medidata company that represents the next horizon of the industry leader’s 20-year mission of powering smarter treatments and healthier people. Acorn AI is designed to make data liquid across the entire lifecycle and to answer the most important questions in R&D and commercialization for customers. Built upon the Medidata platform comprising more than 20,000 trials and 5 million patients, Acorn AI products feature one of the industry’s largest structured, standardized clinical trial data repository connected with real world, translational and other datasets.

Capabilities

CRO Services Center (Phase IV) Provider - Catalyst Clinical Research
Catalyst Clinical Research

Catalyst Clinical Research is a clinical development organization providing highly customizable solutions to the global biopharmaceutical industry. Built from more than two decades of listening to their customers, devising customer-centric solutions and helping them breakthrough with clinical development programs surrounded by therapeutically aligned teams of experts.

Capabilities

CRO Services Center (Phase IV) Provider - Ciox Real World Data
Ciox Real World Data

Utilizing its DataFit Platform™, the Ciox Real World Data division (Ciox RWD) securely and consistently curates disparate data sets to enable researchers to access valuable clinical information that may otherwise be hidden in or across different parts of workflow systems that house medical records. The Ciox DataFit Platform™ utilizes clinical rules-based medical concept translation with unstructured data sets to build highly structured clinical data that can be used by researchers to advance care for patients.

Capabilities


Have questions about selecting the right Phase IV service provider?

The Clinical Leader team can help. We'll match your needs with the right companies.

Contact us via email for assistance.


CRO Services Center (Phase IV) Provider - Cytel
Cytel

Now more than ever, the clinical development path is full of make-or-break data complexities and analytical challenges. As a pioneer in evidence generation, with deep expertise in advanced analytical solutions, we are uniquely equipped to unlock the value from increasingly complex data. Life Sciences companies count on Cytel to deliver exceptional insight, minimize trial risk and accelerate the development of promising new medicines that improve human life.

Capabilities

CRO Services Center (Phase IV) Provider - PAREXEL
Parexel

Parexel is in the business of improving the world’s health. We do this by providing a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments. From clinical trials to regulatory, consulting, and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.

CRO Services Center (Phase IV) Provider - Premier Research
Premier Research

Premier Research recognizes that when an emerging biotech is built around a single asset, focus and flexibility are critical to success. And, since many of our customers require additional infrastructure, we fill in resourcing gaps to help their product reach the patient faster. We are a mid-size CRO and offer strategies that are customized for each program, with tailored processes designed to meet highly specific needs.


CRO Services Center (Phase IV) Provider - Rho
Rho

Rho, a privately held CRO located in RTP, NC, provides clinical research services across the entire drug development process. Since 1984, Rho has been a trusted partner to the industry’s leading pharmaceutical, biotechnology, medical device companies, and academic and government organizations. Our commitment to excellence, innovative technologies, and therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience.

CRO Services Center (Phase IV) Provider - United BioSource - UBC
United BioSource - UBC

United BioSource LLC (UBC) is a leading provider of pharmaceutical support services, partnering with life science companies to make medicine and medical products safer and more accessible. UBC is well known for our expertise in generating authoritative, real-world evidence of product effectiveness, safety, and value to assist healthcare decisions and enhance patient care.

CRO Services Center (Phase IV) Provider - WCG
WCG

WCG is the world's leading strategic partner to sponsors, CROs, institutions, and sites providing agile, knowledge based services that proactively optimize clinical development programs.


CRO Services Center (Phase IV) Provider - Worldeide Clinical Trials
Worldwide Clinical Trials

Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.

Capabilities